Histologic or cytologic confirmation of head and neck malignancy without evidence of metastatic disease
Item
histologic or cytologic confirmation of head and neck malignancy without clinical or radiographic evidence of metastatic disease
boolean
C0449575 (UMLS CUI [1,1])
C0018671 (UMLS CUI [1,2])
C1709236 (UMLS CUI [2])
Locally advanced hn scc, stages iii, iv and bulky stage ii, exluding larynx and nasopharynx
Item
locally advanced hn scc, stages iii, iv, and bulky (> 27 cm^3 volume) stage ii, excluding larynx and nasopharynx, of no more than 150 cm^3 volume base on ct scan
boolean
C0677984 (UMLS CUI [1,1])
C1168401 (UMLS CUI [1,2])
C0332300 (UMLS CUI [1,3])
C0023078 (UMLS CUI [1,4])
C0027442 (UMLS CUI [1,5])
C1300072 (UMLS CUI [1,6])
C0475440 (UMLS CUI [1,7])
Informed consent
Item
all patients must be informed of the investigational nature of this study and must give written informed consent in accordance with institutional and federal guidelines
boolean
C0021430 (UMLS CUI [1])
Eligible for chemotherapy
Item
candidate for chemotherapy
boolean
C1548635 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Zubrod performance score
Item
zubrod performance score of 0 or 1
boolean
C3714786 (UMLS CUI [1])
absolute granulocyte count (agc) >= 2000 cells/mm^3
Item
absolute granulocyte count (agc) >= 2000 cells/mm^3
boolean
C0857490 (UMLS CUI [1])
platelet count >= 100,000 cells/mm^3
Item
platelet count >= 100,000 cells/mm^3
boolean
C0032181 (UMLS CUI [1])
Hemoglobin > 8.0 g/dl
Item
hemoglobin > 8.0 g/dl based upon cbc/differential obtained within 2 weeks prior to registration on study
boolean
C0019046 (UMLS CUI [1])
Serum creatinine =< 1.5 mg/dl or measured or calculated creatinine clearance >= 50 ml/min
Item
serum creatinine =< 1.5 mg/dl or measured or calculated creatinine clearance >= 50 ml/min
boolean
C0201976 (UMLS CUI [1])
C0017654 (UMLS CUI [2])
Negative pregnancy test
Item
negative pregnancy test within 2 weeks prior to registration for women of childbearing potential
boolean
C0427780 (UMLS CUI [1])
prior invasive malignancy except non-melanomatous skin cancers
Item
prior invasive malignancy except non-melanomatous skin cancers unless patient has been disease free for at least 3 years
boolean
C2735087 (UMLS CUI [1])
C0332300 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1518408 (UMLS CUI [2,3])
Prior cancer treatment for this cancer, including gross total tumor excision
Item
prior cancer treatment for this cancer, including gross total tumor excision
boolean
C1514463 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0027651 (UMLS CUI [2,1])
C0728940 (UMLS CUI [2,2])
Prior radiation treatment to the hn region
Item
prior radiation treatment to the hn region
boolean
C0279134 (UMLS CUI [1,1])
C0460004 (UMLS CUI [1,2])
Known syndromes that alter radiosensitivity
Item
patients with known syndromes that alter radiosensitivity
boolean
C0243087 (UMLS CUI [1,1])
C4054723 (UMLS CUI [1,2])
C0034537 (UMLS CUI [1,3])
Medical contraindications for chemotherapy
Item
any medical contraindications for chemotherapy
boolean
C1301624 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Pregnant or lactating women
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0022925 (UMLS CUI [2])
Not willing/able to use a medically acceptable form of contraception
Item
women (of childbearing potential) and men who are sexually active and are not willing/able to use a medically acceptable form of contraception throughout the treatment and 60 days thereafter
boolean
C0558080 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C1299582 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])